Initial impact of drug-eluting stents on coronary artery bypass grafting

International Heart Journal

Volumn 48, Issue 4, 2007, Pages 455-461

  Ishikawa, Susumu ^a   Kawasaki, Akio ^a   Neya, Kazu ^a   Wada, Shinichi ^a   Kito, Hiroaki ^a   Ueda, Keisuke ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary artery bypass grafting; Cypher; Drug eluting stent; Percutaneous coronary intervention

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; AORTA BALLOON; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CRITICALLY ILL PATIENT; DRUG ELUTING STENT; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OFF PUMP CORONARY SURGERY; OUTCOME ASSESSMENT; PATIENT REFERRAL; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SURGICAL MORTALITY; SURVIVAL RATE;

AGE FACTORS; AGED; ANGIOPLASTY, BALLOON, LASER-ASSISTED; CORONARY ARTERY BYPASS; CORONARY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE;

EID: 34648827873     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.48.455     Document Type: Article

References (21)

1. Sousa JE, Costa MA, Abizaid AC, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 2001; 104: 2007-11.
2. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-80.
3. Ozcan T, Cin VG, Yurtdas M, et al. Angiographic and clinical outcome following sirolimus-eluting stent (cypher) implantation. Int Heart J 2007; 48: 11-23.
4. van Domburg RT, Lemos PA, Takkenberg JJ, et al. The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease. Eur Heart J 2005; 26: 675-81.
5. Palmerini T, Marzocchi A, Marrozzini C, et al. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry). Am J Cardiol 2006; 98: 54-9.
6. Baim DS. New devices for percutaneous coronary intervention arc rapidly making bypass surgery obsolete. Curr Opin Cardiol 2004; 19: 593-7.
7. Liddicoat JR, De La Torre R, Ho W et al. Initial impact of drug-eluting stents on coronary artery bypass graft surgery. Ann Thorac Surg 2006; 81: 1239-42.
8. Ferreira AC, Peter AA, Salemo TA, Bolooki H, de Marchena, E. Clinical impact of drug-eluting stents in changing referral practices for coronary surgical revascularization in a tertiary care center. Ann Thorac Surg 2003; 75: 485-9.
9. Powell BD, Rihal CS, Bell MR, Zehr KJ, Holmes DR Jr. Anticipated impact of drug-eluting stents on referral patterns for coronary artery bypass graft surgery: a population based angiographic analysis. Mayo Clin Proc 2004; 79: 769-72.
10. Cohn WE. Surgical coronary revascularization remains relevant in the era of stents. Curr Opin Cardiol 2004; 19: 589-92. (Review)
11. Chieffo A, Monci N, Maisano F, et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation 2006; 113: 2542-7.
12. Kappetein AP, Dawkins KD, Mohr FW, et al. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase. Eur J Cardiothorac Surg 2006; 29: 486-91.
13. Guyton RA. Coronary artery bypass is superior to drug-eluting stents in multivessel coronary artery disease. Ann Thorac Surg 2006; 81: 1949-57. (Review)
14. Shirakabe A, Takano H, Nakamura S, et al. Coronary perforation during percutaneous coronary intervention. Int Heart J 2007; 48: 1-9.
15. Moshkovitz Y, Mohr R, Braunstein R, et al. Revascularization of left anterior descending coronary artery in patients with single and multivessel disease: comparison between off-pump internal thoracic artery and drug-eluting stent. Chest 2005; 128: 804-9.
16. Vassiliades TA Jr, Douglas JS, Morris DC, et al. Integrated coronary revascularization-with drug-eluting stents: immediate and seven-month outcome. J Thorac Cardiovasc Surg 2006; 131: 956-62.
17. Murphy GJ, Bryan AJ, Angelini GD. Hybrid coronary revascularization in the era of drug-eluting stents. Ann Thorac Surg 2004; 78: 1861-7. (Review)
18. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-instituitional cohort study. Lancet 2007; 369:667-78.
19. Luscher TF, Steffel J, Eberh FR, et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 2007; 115: 1051-8. (Review)
20. Yang J, Wang N, Zhang X, et al. Late angiographic stent thrombosis in a drug-eluting stent that occurred 20 months after premature discontinuation of clopidogrel administration. Int Heart J 2006; 47: 707-13.
21. Luthra S, Tatoulis J, Warren RJ. Drug-eluting stent-induced left anterior descending coronary artery aneurysm: repair by pericardial patch - where are we headed? Aim Thorac Surg 2007; 83: 1530-2.